SEI Investments
ANIK icon

SEI Investments’s Anika Therapeutics ANIK Stock Holding History

SEI Investments’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,712
Closed -$635K – 2725
2024
Q3 		$635K Hold
25,712
– – ﹤0.01% 2098
2024
Q2 		$651K Sell
25,712
-3,606
-12% -$93.5K ﹤0.01% 2068
2024
Q1 		$745K Hold
29,318
– – ﹤0.01% 1993
2023
Q4 		$664K Buy
29,318
+4,315
+17% +$89.3K ﹤0.01% 2004
2023
Q3 		$466K Buy
+25,003
New +$519K ﹤0.01% 2135
2020
Q3 		– Sell
-32,682
Closed -$1.21M – 2402
2020
Q2 		$1.21M Sell
32,682
-76
-0.2% -$2.5K ﹤0.01% 1479
2020
Q1 		$927K Buy
32,758
+9,990
+44% +$404K ﹤0.01% 1492
2019
Q4 		$1.15M Buy
22,768
+43
+0.2% +$2.5K ﹤0.01% 1591
2019
Q3 		$1.22M Buy
+22,725
New +$1.17M ﹤0.01% 1534
2019
Q2 		– Sell
-9,279
Closed -$281K – 2394
2019
Q1 		$281K Buy
9,279
+7,193
+345% +$246K ﹤0.01% 2151
2018
Q4 		$70K Buy
+2,086
New +$75.3K ﹤0.01% 2270
2018
Q1 		– Sell
-3,046
Closed -$171K – 3452
2017
Q4 		$171K Sell
3,046
-40,881
-93% -$2.26M ﹤0.01% 1979
2017
Q3 		$6.16M Buy
+43,927
New +$2.3M 0.02% 792
2017
Q1 		– Sell
-4,111
Closed -$503K – 2899
2016
Q4 		$503K Buy
+4,111
New +$190K ﹤0.01% 1571

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

SEI Investments's ANIK Position: Q4 2024 in Review

SEI Investments sold out of Anika Therapeutics (ANIK) in Q4 2024, closing a stake of 25,712 shares — an estimated $635K sold.

SEI Investments first reported a position in ANIK in Q4 2016 and held it in 14 quarters. The position peaked at $6.16M in Q3 2017. 109 funds tracked by Wall St. Rank hold ANIK as of Q4 2024.

  • SEI Investments reported no remaining Anika Therapeutics position as of Q4 2024 after selling out during the quarter.
  • SEI Investments sold 25,712 Anika Therapeutics shares in Q4 2024, an estimated $635K.
  • SEI Investments first reported a position in Anika Therapeutics in Q4 2016 and held it in 14 quarters.
  • SEI Investments's Anika Therapeutics position peaked at $6.16M in Q3 2017.
  • 109 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2024.

Based on SEI Investments's 13F filing for Q4 2024, filed 11 Feb 2025.